A hysterectomy is not a standard treatment for PCOS, and in most cases it would not resolve the condition. PCOS is a hormonal and metabolic disorder that affects your entire endocrine system, not just your uterus or ovaries. Removing the uterus eliminates certain risks that come with PCOS, like abnormal bleeding and endometrial cancer, but it leaves the underlying hormonal imbalances, insulin resistance, and metabolic issues completely untouched. That said, there are specific situations where a hysterectomy becomes a reasonable option for someone who also has PCOS.
Why a Hysterectomy Doesn’t Treat PCOS
PCOS affects 4 to 18% of reproductive-age women and involves far more than the reproductive organs. The condition drives insulin resistance in roughly 65 to 70% of women who have it, regardless of body weight. It disrupts the production of sex hormones, interferes with ovulation, and raises long-term risks for type 2 diabetes and cardiovascular disease. The name “polycystic ovary syndrome” is actually misleading. About one in four women with PCOS don’t even have cysts on their ovaries, and a 2012 NIH panel recommended renaming the condition to better reflect its complexity.
Because PCOS originates in your hormonal and metabolic systems rather than in the uterus itself, removing the uterus doesn’t correct the root problem. After a hysterectomy, you would still have the same insulin resistance, the same elevated androgen levels driving symptoms like excess hair growth and acne, and the same metabolic risks. If anything, research suggests a hysterectomy could worsen some of these issues. Women who have had a hysterectomy, even without ovary removal, face a 50% higher risk of developing type 2 diabetes compared to women who haven’t. The decrease in estrogen production that follows hysterectomy appears to impair glucose tolerance and increase insulin resistance.
When a Hysterectomy May Be Warranted
While PCOS alone isn’t an indication for hysterectomy, PCOS can cause complications that eventually make surgery necessary. The most significant is the increased risk of endometrial cancer. Women with PCOS are about four times more likely to develop endometrial cancer than women without the condition. For premenopausal women specifically, the risk jumps to roughly five times higher. The general population faces about a 3% lifetime risk of endometrial cancer; for women with PCOS, that estimate rises to 12 to 15%.
This elevated cancer risk exists because PCOS disrupts ovulation. When you don’t ovulate regularly, your body produces estrogen without the balancing effect of progesterone. That unopposed estrogen stimulates the uterine lining month after month, causing it to thicken abnormally, a condition called endometrial hyperplasia. Left unmanaged, hyperplasia can progress to cancer. If monitoring reveals atypical hyperplasia or early-stage endometrial cancer, a hysterectomy becomes a clear medical recommendation.
A hysterectomy might also be considered when PCOS coexists with other uterine conditions that haven’t responded to less invasive approaches. Severe, uncontrollable uterine bleeding that fails to improve with hormonal treatments, or the presence of large fibroids alongside PCOS symptoms, can tip the scale toward surgery. In these cases the hysterectomy addresses the uterine problem specifically, not the PCOS.
What Happens if Ovaries Are Also Removed
Some women with PCOS wonder whether removing the ovaries along with the uterus would finally eliminate the hormonal chaos. This approach carries serious trade-offs. Removing the ovaries causes an abrupt halt in estrogen production, triggering immediate surgical menopause. For women with PCOS, who already struggle with insulin resistance, this sudden estrogen loss can worsen glucose tolerance and further increase diabetes risk. The combination of hysterectomy with ovary removal has been linked to greater impairment in carbohydrate metabolism than hysterectomy alone.
Keeping the ovaries intact during a hysterectomy preserves some hormonal function, but even this isn’t entirely neutral. Hysterectomy without ovary removal can still affect how well the ovaries work over time, and the metabolic consequences remain a concern. For most women with PCOS, preserving ovarian function is the safer path when surgery is necessary for other reasons.
Alternatives That Target the Real Risks
The good news is that the uterine risks PCOS creates, particularly the thickening of the endometrial lining, can be managed effectively without surgery. A progestin-releasing IUD is one of the most practical options. The device releases a small, steady dose of a synthetic progesterone directly into the uterus, about 20 micrograms per day, for up to five years. This thins the uterine lining and counteracts the effects of unopposed estrogen. Because only about 10% of the hormone enters the bloodstream, it has almost no impact on ovarian function or systemic hormone levels.
In clinical studies, the progestin IUD reduced endometrial thickness to about 5 millimeters after three months, compared to over 7 millimeters with oral progesterone pills. It also proved more effective at controlling abnormal bleeding, with a 95% clinical effectiveness rate versus roughly 78% for oral medication. Over 90% of women using the device reported better outcomes, and most experienced significantly lighter periods. For women with PCOS who are dealing with heavy, irregular bleeding or who need to protect their endometrial lining, this approach addresses the uterine problem directly while leaving the rest of the body’s hormonal system undisturbed.
Cyclic oral progesterone is another option. Taking progesterone for 10 to 14 days each month triggers a withdrawal bleed that sheds the uterine lining, preventing dangerous buildup. Combined hormonal contraceptives serve a similar purpose by regulating the menstrual cycle and providing consistent progesterone exposure.
Managing PCOS Beyond the Uterus
Because PCOS is fundamentally a metabolic condition, the most effective management targets insulin resistance and hormonal balance rather than any single organ. Addressing insulin resistance through lifestyle changes or medication can improve ovulation, reduce androgen levels, and lower cardiovascular risk. Weight loss of even 5 to 10% of body weight, when applicable, often produces measurable improvements in cycle regularity and metabolic markers.
For women who have finished having children and whose PCOS-related uterine symptoms are severe and resistant to all other treatments, a hysterectomy remains a valid conversation to have with a gynecologist. But it’s important to go into that conversation understanding what a hysterectomy can and cannot do. It can eliminate bleeding problems and remove endometrial cancer risk. It cannot fix the hormonal imbalances, insulin resistance, or metabolic features that define PCOS. Those will require ongoing management regardless of whether the uterus stays or goes.